ATORVASTATIN 10 MG TABLET

ATORVASTATIN CALCIUM
$0.0254per EA
High Outlier

Strength

10 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097094415

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

2/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205519

On Market Since

11/16/2017

Pharmacological Classes

HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

-1.3%

6M

+3.7%

1Y

-8.9%

3Y

-18.4%

5Y

-32.3%

All

-57.9%